Bioavailability of reetally administered valproic acid syrup

James C. Cloyd, Robert L. Kriel

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

The bioavailability of commercially available valproic acid (VPA) syrup was studied following rectal administration in both dogs and children. Six dogs were studied following both oral (PO) and rectal (PR) administration of a dilute VPA syrup given in a dose of 40 mg per kilogram. There was no significant difference (p >0.10) in the area under the serum concentration-time curve (AUC) between the oral (201.1 mg L1hr) and rectal (219.6mg L1hr) routes of administration. Four children were given VPA syrup by the rectal route. In three patients on maintenance VPA therapy, absorption following rectal administration was similar to that following oral administration. In a fourth child, VPA serum levels following an initial rectal dose of 20 mg per kilogram reached a maximum of 42 mg per liter 2 hours after the drug was given. These results indicate that the bioavailability of a diluted VPA syrup given reetally is comparable to that following oral administration. Rectal administration of VPA syrup appears to be a satisfactory alternative when the oral route is unavailable.

Original languageEnglish (US)
Pages (from-to)1348-1352
Number of pages5
JournalNeurology
Volume31
Issue number10
DOIs
StatePublished - Oct 1981

Fingerprint

Dive into the research topics of 'Bioavailability of reetally administered valproic acid syrup'. Together they form a unique fingerprint.

Cite this